Axsome Therapeutics (AXSM) Net Margin: 2022-2025
Historic Net Margin for Axsome Therapeutics (AXSM) over the last 3 years, with Sep 2025 value amounting to -27.62%.
- Axsome Therapeutics' Net Margin rose 3404.00% to -27.62% in Q3 2025 from the same period last year, while for Sep 2025 it was -40.89%, marking a year-over-year increase of 5098.00%. This contributed to the annual value of -74.47% for FY2024, which is 1394.00% up from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Net Margin is -27.62%, which was up 13.54% from -31.95% recorded in Q2 2025.
- Axsome Therapeutics' Net Margin's 5-year high stood at -11.88% during Q1 2023, with a 5-year trough of -266.08% in Q3 2022.
- In the last 3 years, Axsome Therapeutics' Net Margin had a median value of -63.08% in 2024 and averaged -74.24%.
- Per our database at Business Quant, Axsome Therapeutics' Net Margin soared by 15,849bps in 2023 and then slumped by 7,926bps in 2024.
- Over the past 4 years, Axsome Therapeutics' Net Margin (Quarterly) stood at -251.29% in 2022, then surged by 11,339bps to -137.89% in 2023, then surged by 7,482bps to -63.08% in 2024, then surged by 3,404bps to -27.62% in 2025.
- Its last three reported values are -27.62% in Q3 2025, -31.95% for Q2 2025, and -48.91% during Q1 2025.